Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Us2.ai and Ventripoint integrated into Ascend's Gen3Echo 🚀
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Comment by jopatcloon Aug 29, 2024 10:15am
65 Views
Post# 36201078

RE:RE:RE:Us2.ai and Ventripoint integrated into Ascend's Gen3Echo 🚀

RE:RE:RE:Us2.ai and Ventripoint integrated into Ascend's Gen3Echo 🚀Interesting  post Us2.ai on Linkedin


It almost time for ESCCongress 2024!
Loads of people hard at work to build stands, check sound and lighting!
Things are looking great!!

You can already feel the buzz!

Us2.ai, come meet us in the digital health area between the digital health stage and room Bern!

Christine Gouillard Yoran M. Hummel Nathan Simcox Sabrina Fekecs

Us2.ai at ESCCongress 2024
Bringing the future of Echocardiography and trials to ESC Congress London
 Solution for Core Lab

 Core Lab Applications

Elevate your Core Lab Research with AI-Echo precision and automate your workflow with our unique custom solution: US2.CloudLab
US2.AI provides innovative solutions, transforming how trials are conducted

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities